This study is in progress, not accepting new patients
A Study of Experimental Medicine VAY736 For Autoimmune Hepatitis
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UC Davis
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT03217422
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- About 68 people participating
- Last Updated